Deregulation of HER2 Downstream Signaling in Breast Cancer Cells by a Cocktail of Anti-HER2 scFvs

  • Foroogh Nejatollahi, Reza Ranjbar, Vahid Younesi, Mahdi Asgharpour
  • Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, July 2013, Cognizant Communication Corporation
  • DOI: 10.3727/096504013x13657689382734

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.3727/096504013x13657689382734

The following have contributed to this page: Foroogh Nejatollahi